U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H12FN5O2
Molecular Weight 253.233
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LODENOSINE

SMILES

NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](CO)C[C@@H]3F

InChI

InChIKey=KBEMFSMODRNJHE-JFWOZONXSA-N
InChI=1S/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1

HIDE SMILES / InChI

Molecular Formula C10H12FN5O2
Molecular Weight 253.233
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Lodenosine is the experimental HIV reverse transcriptase inhibitor. It was designed as a chemically and enzymatically stable anti-AIDS drug. A phase II trial of the nucleoside analog lodenosine was suspended after one participant died and others showed signs of liver or kidney damage.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
3.0 µM [Ki]
PubMed

PubMed

TitleDatePubMed
Synthesis of fluorinated nucleosides.
2006-07
Determination of carrier-mediated transport of 2',3'-dideoxypurine nucleosides in the rat ileum using a bidirectional perfusion technique.
2004-02
A facile synthetic method for 3'-alpha-fluoro-2',3'-dideoxyadenosine.
2003-10-21
An industrial process for synthesizing Lodenosine (FddA).
2003-10-21
Synthesis of 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine (FddA) via a purine 3'-deoxynucleoside.
2001-11-02
Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
2001-09
High performance liquid chromatography analysis of 9-(2',3'-dideoxy-2'beta-fluoro-D-threo-penta furanosyl) adenine and its metabolite in human plasma using solid-phase extraction on a polyfluorinated reversed stationary phase.
2001-06
Evaluation of a fluorogenic derivatization method for the reversed-phase HPLC analysis of 2'-beta-fluoro-2',3'-dideoxyadenosine, a new anti-AIDS drug.
2001-05
Fluorometric determination of 2'-beta-fluoro-2',3'-dideoxyadenosine 5'-triphosphate, the active metabolite of a new anti-human immunodeficiency virus drug, in human lymphocytes.
2001-01-01
CycloSal-2'-ara(ribo)-fluoro-2',3'-dideoxyadenosine monophosphates--an effort to solve the structure-activity relationship of 2'-fluoro-ddA.
1999-08-05
cycloSal-Pronucleotides of 2'-fluoro-ara- and 2'-fluoro-ribo-2',3'- dideoxyadenosine as a strategy to bypass a metabolic blockade.
1999-05-06
In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.
1997-06
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
1996-04-12
Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
1995-11
Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells.
1995-07-17
Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs.
1991-05
Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV.
1990-03
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
1988-04-01
Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis.
1987-11
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV).
1987-09-01
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:06:59 GMT 2025
Edited
by admin
on Mon Mar 31 18:06:59 GMT 2025
Record UNII
3WB2LGT4R1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LODENOSINE
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
NSC-613792
Preferred Name English
Lodenosine [WHO-DD]
Common Name English
9H-PURIN-6-AMINE, 9-(2,3-DIDEOXY-2-FLUORO-.BETA.-D-THREO-PENTOFURANOSYL)-
Systematic Name English
LODENOSINE [USAN]
Common Name English
F-DDA
Code English
lodenosine [INN]
Common Name English
2'-.BETA.-FLUORO-2',3'-DIDEOXYADENOSINE
Common Name English
9-(2,3-DIDEOXY-2-FLUORO-.BETA.-D-THREO-PENTOFURANOSYL) ADENINE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1556
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
NCI_THESAURUS C97452
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
Code System Code Type Description
CAS
110143-10-7
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
FDA UNII
3WB2LGT4R1
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
NSC
613792
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
SMS_ID
100000082016
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
EPA CompTox
DTXSID90149154
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
PUBCHEM
72180
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
EVMPD
SUB08550MIG
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
INN
7654
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
ChEMBL
CHEMBL501916
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
WIKIPEDIA
LODENOSINE
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
MESH
C073072
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
NCI_THESAURUS
C1499
Created by admin on Mon Mar 31 18:06:59 GMT 2025 , Edited by admin on Mon Mar 31 18:06:59 GMT 2025
PRIMARY
Related Record Type Details
METABOLITE ACTIVE -> PARENT
gag protein expression; protection from cytopathogenic effects of HIV-1 or -2; anti-HIV-1 activity
IN-VITRO
METABOLITE ACTIVE -> PARENT
IN-VITRO
Related Record Type Details
ACTIVE MOIETY